2025年2月7日 · The PDAC is working with manufacturers and distributors to identify all hydrophilic intermittent urinary catheters listed on the Product Classification List (PCL) to ensure they are properly coded A4295, A4296 or A4297.

The annual award winning PDAC Convention in Toronto, Canada brings together 27,000 attendees from over 135 countries for its educational programming, networking events, business opportunities and fun.

2021年9月7日 · Importance: Pancreatic ductal adenocarcinoma (PDAC) is a relatively uncommon cancer, with approximately 60 430 new diagnoses expected in 2021 in the US. The incidence of PDAC is increasing by 0.5% to 1.0% per year, and it is projected to become the second-leading cause of cancer-related mortality by 2030.

PDAC is a disease with increased heterogeneity and exhibits unique immunologic hallmarks. The principal basis of cancer immunotherapy is to activate a patient’s T cells so that they can kill their tumors.

2022年8月12日 · Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive form of cancer and the most common type of pancreatic cancer. It makes up more than 90% of pancreatic cancers and leads to...

Pancreatic ductal adenocarcinoma (PDAC), which constitutes 90% of pancreatic cancers, is the fourth leading cause of cancer-related deaths in the world. Due to the broad heterogeneity of genetic mutations and dense stromal environment, PDAC belongs ...

2022年3月29日 · Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is most frequently detected at advanced stages, limiting treatment options to systemic chemotherapy with modest clinical...

2021年12月17日 · Pancreatic ductal adenocarcinoma (PDAC) is a clinically challenging cancer, due to both its late stage at diagnosis and its resistance to chemotherapy. However, recent advances in our understanding of the biology of PDAC have revealed new opportunities for early detection and targeted therapy of PDAC.

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal malignancy with a high rate of recurrence and a dismal 5‐year survival rate. Contributing to the poor prognosis of PDAC is the lack of early detection, a complex network of ...

Pancreatic ductal adenocarcinoma (PDAC) is a malignancy characterized by a poor prognosis and high mortality rate.The typical histopathology of PDAC comprises clusters of moderately-to-poorly differentiated cancer cells embedded within an exuberant desmoplastic stroma, consisting of Extracellular matrix (ECM), Cancer-associated fibroblasts ...